Brett Lanier

Brett Lanier currently serves as an Advisory Board Member for the North Carolina Biotechnology Center and holds the position of President at Isosceles Pharmaceuticals, an early-stage startup focused on developing postoperative acute pain products. Previous experience includes roles as U.S. Commercial Director at Noramco™, where strategic decisions led to sales growth and market share maximization, and Senior Manager - Global Commercial API at Mallinckrodt Pharmaceuticals, where new high-earning accounts for controlled substances and other products were secured. Brett Lanier has also contributed as Sales Manager at LAUDA-Brinkmann, LP., Account Manager at Kse Scientific, and Sales Associate at Medtronic Spine & Biologics. Educational qualifications include a degree in Private Equity and Venture Capital from Harvard Business School and a Bachelor's degree in Medicinal and Pharmaceutical Chemistry from the University of North Carolina Wilmington.